IL163719A0 - Use of substituted phenyl-5-alkoxy-1,3,4-oxdiazol-2-ones for producing medicaments with an inhibitory effect on pancreatic lipase - Google Patents
Use of substituted phenyl-5-alkoxy-1,3,4-oxdiazol-2-ones for producing medicaments with an inhibitory effect on pancreatic lipaseInfo
- Publication number
- IL163719A0 IL163719A0 IL16371903A IL16371903A IL163719A0 IL 163719 A0 IL163719 A0 IL 163719A0 IL 16371903 A IL16371903 A IL 16371903A IL 16371903 A IL16371903 A IL 16371903A IL 163719 A0 IL163719 A0 IL 163719A0
- Authority
- IL
- Israel
- Prior art keywords
- oxdiazol
- alkoxy
- ones
- substituted phenyl
- inhibitory effect
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10208986A DE10208986A1 (en) | 2002-02-28 | 2002-02-28 | Use of substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one for the production of medicaments with an inhibitory effect on the pancreatic lipase |
| PCT/EP2003/001560 WO2003072098A1 (en) | 2002-02-28 | 2003-02-17 | Use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-one for producing medicaments that inhibit pancreatic lipase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163719A0 true IL163719A0 (en) | 2005-12-18 |
Family
ID=27740557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16371903A IL163719A0 (en) | 2002-02-28 | 2003-02-17 | Use of substituted phenyl-5-alkoxy-1,3,4-oxdiazol-2-ones for producing medicaments with an inhibitory effect on pancreatic lipase |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1482929A1 (en) |
| JP (1) | JP2005519079A (en) |
| KR (1) | KR20040101250A (en) |
| CN (1) | CN1638766A (en) |
| AR (1) | AR038702A1 (en) |
| AU (1) | AU2003210292A1 (en) |
| BR (1) | BR0308045A (en) |
| CA (1) | CA2477005A1 (en) |
| CO (1) | CO5611144A2 (en) |
| DE (1) | DE10208986A1 (en) |
| HR (1) | HRP20040783A2 (en) |
| HU (1) | HUP0500093A2 (en) |
| IL (1) | IL163719A0 (en) |
| MA (1) | MA27173A1 (en) |
| MX (1) | MXPA04007480A (en) |
| NO (1) | NO20044091L (en) |
| PL (1) | PL371310A1 (en) |
| RU (1) | RU2004128932A (en) |
| TW (1) | TW200400026A (en) |
| WO (1) | WO2003072098A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1765327B1 (en) | 2004-06-17 | 2014-08-13 | Cytokinetics, Inc. | Compounds, compositions and methods |
| CA2585175A1 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| AR058347A1 (en) | 2005-12-15 | 2008-01-30 | Cytokinetics Inc | ENTITIES CHEMIES COMPOSITIONS AND METHODS |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| WO2007078839A2 (en) | 2005-12-19 | 2007-07-12 | Cytokinetics, Inc. | Compounds, compositions and methods |
| TWI415607B (en) * | 2007-12-25 | 2013-11-21 | Kissei Pharmaceutical | Novel catechol derivatives, pharmaceutical compositions containing the same and their uses |
| AR074978A1 (en) | 2008-12-23 | 2011-03-02 | Bial Portela & Ca Sa | 3-N-ARIL-1,3,4-OXADIAZOLONAS 5-O-SUBSTITUTED FOR USE IN PAIN TREATMENT AND PROCEDURE OF OBTAINING |
| CN103086859B (en) * | 2011-11-08 | 2015-11-11 | 清华大学 | 2,4-dihydroxyl-5,6-replaces-1-halogeno-benzene derivative, its synthetic method and application thereof |
| AU2018326396B2 (en) * | 2017-09-01 | 2023-10-26 | Falasca, Marco PROF | Synthetic derivatives of oleoyl-lysophosphatidylinositol (oleolyl-LPI) and uses thereof |
| CN109879839B (en) * | 2019-03-12 | 2023-04-25 | 沈阳大学 | 6-piperazinemethyl-7-hydroxy benzofuran compound and medical application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19942354A1 (en) * | 1999-09-04 | 2001-03-08 | Aventis Pharma Gmbh | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, their manufacture and use in medicinal products |
| BR0108974A (en) * | 2000-03-07 | 2003-06-03 | Aventis Pharma Gmbh | Substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazol-2-ones and their use for inhibition of hormone sensitive lipases |
-
2002
- 2002-02-28 DE DE10208986A patent/DE10208986A1/en not_active Withdrawn
-
2003
- 2003-02-17 CA CA002477005A patent/CA2477005A1/en not_active Abandoned
- 2003-02-17 WO PCT/EP2003/001560 patent/WO2003072098A1/en not_active Application Discontinuation
- 2003-02-17 AU AU2003210292A patent/AU2003210292A1/en not_active Abandoned
- 2003-02-17 KR KR10-2004-7013470A patent/KR20040101250A/en not_active Application Discontinuation
- 2003-02-17 IL IL16371903A patent/IL163719A0/en unknown
- 2003-02-17 MX MXPA04007480A patent/MXPA04007480A/en unknown
- 2003-02-17 PL PL03371310A patent/PL371310A1/en not_active Application Discontinuation
- 2003-02-17 EP EP03742942A patent/EP1482929A1/en not_active Withdrawn
- 2003-02-17 RU RU2004128932/15A patent/RU2004128932A/en not_active Application Discontinuation
- 2003-02-17 HU HU0500093A patent/HUP0500093A2/en unknown
- 2003-02-17 JP JP2003570844A patent/JP2005519079A/en not_active Withdrawn
- 2003-02-17 BR BR0308045-5A patent/BR0308045A/en not_active Application Discontinuation
- 2003-02-17 CN CNA038047675A patent/CN1638766A/en active Pending
- 2003-02-26 AR ARP030100625A patent/AR038702A1/en unknown
- 2003-02-26 TW TW092103972A patent/TW200400026A/en unknown
-
2004
- 2004-07-27 MA MA27804A patent/MA27173A1/en unknown
- 2004-08-26 CO CO04083781A patent/CO5611144A2/en not_active Application Discontinuation
- 2004-08-27 HR HR20040783A patent/HRP20040783A2/en not_active Application Discontinuation
- 2004-09-27 NO NO20044091A patent/NO20044091L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1638766A (en) | 2005-07-13 |
| RU2004128932A (en) | 2005-04-10 |
| AU2003210292A1 (en) | 2003-09-09 |
| HUP0500093A2 (en) | 2005-04-28 |
| DE10208986A1 (en) | 2003-09-11 |
| HRP20040783A2 (en) | 2005-04-30 |
| MXPA04007480A (en) | 2004-11-10 |
| WO2003072098A1 (en) | 2003-09-04 |
| KR20040101250A (en) | 2004-12-02 |
| CA2477005A1 (en) | 2003-09-04 |
| TW200400026A (en) | 2004-01-01 |
| EP1482929A1 (en) | 2004-12-08 |
| CO5611144A2 (en) | 2006-02-28 |
| BR0308045A (en) | 2004-12-21 |
| JP2005519079A (en) | 2005-06-30 |
| AR038702A1 (en) | 2005-01-26 |
| MA27173A1 (en) | 2005-01-03 |
| PL371310A1 (en) | 2005-06-13 |
| NO20044091L (en) | 2004-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1249850A1 (en) | Method for the treatment of multiple sclerosis | |
| ZA200500086B (en) | Novel carboxamide compounds having an MCH-antagonistic effect, medicaments containing said compounds, and method for the production thereof | |
| AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
| ZA200302553B (en) | Arrangement of radial bogie. | |
| AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
| AU2003257465A1 (en) | Substituted diaryl heterocycles, method for the production and use thereof as medicaments | |
| HK1087103A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| EP1426370A4 (en) | Propanolamine derivative having 1,4 benzodioxane ring | |
| AU2003258145A1 (en) | Substituted phenylindoles for the treatment of hiv | |
| AU2003288023A1 (en) | Process for the manufacture of 1,2-epoxy-3-chloropropane | |
| AU2003298913A1 (en) | Treatment of inflammatory disorders with 2,3-benzodiazepines | |
| IL163719A0 (en) | Use of substituted phenyl-5-alkoxy-1,3,4-oxdiazol-2-ones for producing medicaments with an inhibitory effect on pancreatic lipase | |
| WO2003079962A3 (en) | Assembled unit consisting of individually separable transdermal therapeutic systems | |
| AU2003233820A1 (en) | Method for the treatment of starch | |
| AU2002353510A1 (en) | Nebuliser | |
| AU2003201163A1 (en) | Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol | |
| AU2003293477A1 (en) | Method for the production of polycarbonates | |
| AU2003210287A1 (en) | Coolant distributor | |
| AU2003258622A1 (en) | Method for the production of $g(b)-carotinoids | |
| AU2003209534A1 (en) | The method of treating tuberculosis | |
| AU2003267541A1 (en) | Method for the production of substituted trifluoroethylenes | |
| AU2003218718A1 (en) | Utilization of ubiquinones for influencing the effect of histamine | |
| NO20041295L (en) | Tieno (1,3) oxazin-4-ones with lipase inhibitory activity | |
| AU2003245879A1 (en) | Method for the production of substituted trifluoroetylenes | |
| AUPS219602A0 (en) | Method for the treatment of multiple sclerosis |